Search results for abx831315

Emactuzumab, Abbexa, abx831315

Emactuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CSF1R/CD115, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Emactuzumab is under investigation in clinical trial NCT01494688 (A Study of RO5509554 as Monotherapy and in Combination With Paclitaxel in Participants With Advanced Solid Tumors).